Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3, is the first ...

even after successful valve surgery. This is according to a new study, "Mitral annular disjunction and mitral valve prolapse: ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery.

People with a certain heart valve defect known as Mitral Annular Disjunction (MAD) may face a significantly higher risk of ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

People with a certain heart valve abnormality may be at an increased risk of developing severe heart rhythm disorders also known as arrhythmias medical news ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study from Karolinska Institutet ...

Followed patients after surgery In the current study, researchers at Karolinska Institutet investigated the risk of cardiac arrhythmias in 599 patients with mitral valve prolapse who underwent ...